Xinzhong Li
Teesside University, UK
Title: An integrated platform for developing brain cancer diagnostic techniques
Biography
Biography: Xinzhong Li
Abstract
There were 17 million new cases of cancer and 8.2 million deaths from cancer worldwide in 2018. It’s estimated that there will be 27.5 million new cases of cancer each year by 2040. Th is causes huge social, political and financial pressures. Different from other cancers, brain tumors deaths are rising, representing 2.6% of all deaths from cancer and kill more children and people under 40 than any other cancers. Every two hours, someone is diagnosed with a brain tumour in England alone. Despite intensive eff orts, there are currently no effective disease-modifying treatments or preventive strategies for brain cancer in part due to the lack of effective early diagnostic techniques. Developing a reliable, less expensive diagnostic technique with short time intervals is utmost important and required for personalized therapy, which may potentially help patients to avoid harmful biopsy. Th e long-term fight against cancer and the lack of young interdisciplinary talents in the brain cancer diagnostic field highly requires intensive training of a new generation of researchers. AiPBAND is proposed to provide such an excellent triple-i (interdisciplinary, intersectoral and international) research and training platform with multidisciplinary expertise and advanced technologies for developing innovative diagnostic techniques for brain cancer. Through this platform, a new generation of innovative, entrepreneurial and creative early-stage researchers (ESRs) will be trained with triple-i knowledge/skills and broad vision to maximize their ability of knowledge transformation and employability, and become the future leaders in both academia and industry. Fighting against cancer and other complex human diseases requires complementary interdisciplinary research eff orts and intensive intersectoral collaborations.